Preclinical Stage Alzheimer's Disease Detection Using Magnetic Resonance Image Scans

Alzheimer's disease is one of the diseases that mostly affects older people without being a part of aging. The most common symptoms include problems with communicating and abstract thinking, as well as disorientation. It is important to detect Alzheimer's disease in early stages so that cognitive functioning would be improved by medication and training. In this paper, we propose two attention model networks for detecting Alzheimer's disease from MRI images to help early detection efforts at the preclinical stage. We also compare the performance of these two attention network models with a baseline model. Recently available OASIS-3 Longitudinal Neuroimaging, Clinical, and Cognitive Dataset is used to train, evaluate and compare our models. The novelty of this research resides in the fact that we aim to detect Alzheimer's disease when all the parameters, physical assessments, and clinical data state that the patient is healthy and showing no symptoms

[1]  Elizabeth Beattie,et al.  Cognitive training for early-stage Alzheimer's disease and dementia. , 2009, Journal of gerontological nursing.

[2]  Jürgen Schmidhuber,et al.  Long Short-Term Memory , 1997, Neural Computation.

[3]  Youngsoon Yang,et al.  Effect of Paper-Based Cognitive Training in Early Stage of Alzheimer's Dementia , 2019, Dementia and neurocognitive disorders.

[4]  Pierre Sermanet,et al.  Attention for Fine-Grained Categorization , 2014, ICLR.

[5]  Ding-Xuan Zhou,et al.  Theory of deep convolutional neural networks: Downsampling , 2020, Neural Networks.

[6]  Daniel S. Marcus,et al.  OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease , 2019 .

[7]  Sergey Ioffe,et al.  Inception-v4, Inception-ResNet and the Impact of Residual Connections on Learning , 2016, AAAI.

[8]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[9]  Suzanne E. Schindler,et al.  Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease , 2017, Neurobiology of Aging.

[10]  D. Knopman,et al.  Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. , 2001, The American journal of managed care.

[11]  W. Markesbery,et al.  Neuropathologic alterations in mild cognitive impairment: a review. , 2010, Journal of Alzheimer's disease : JAD.

[12]  Benedikt Zott,et al.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.

[13]  Yubraj Gupta,et al.  Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers , 2019, Front. Comput. Neurosci..

[14]  Danni Cheng,et al.  Classification of MR brain images by combination of multi-CNNs for AD diagnosis , 2017, International Conference on Digital Image Processing.

[15]  Douglas Galasko,et al.  Alzheimer's disease: The right drug, the right time , 2018, Science.

[16]  H. Robbins.  A Stochastic Approximation Method , 1951 .

[17]  Shin Ando,et al.  Deep Over-sampling Framework for Classifying Imbalanced Data , 2017, ECML/PKDD.

[18]  Andrew Zisserman,et al.  Very Deep Convolutional Networks for Large-Scale Image Recognition , 2014, ICLR.

[19]  Tolga Ertekin,et al.  Total intracranial and lateral ventricle volumes measurement in Alzheimer’s disease: A methodological study , 2016, Journal of Clinical Neuroscience.

[20]  Geoffrey E. Hinton,et al.  On the importance of initialization and momentum in deep learning , 2013, ICML.

[21]  Lukasz Kaiser,et al.  Attention is All you Need , 2017, NIPS.

[22]  Jyoti Islam,et al.  A Novel Deep Learning Based Multi-class Classification Method for Alzheimer's Disease Detection Using Brain MRI Data , 2017, BI.

[23]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[24]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[25]  Yulia Dodonova,et al.  Residual and plain convolutional neural networks for 3D brain MRI classification , 2017, 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017).

[26]  Sterling C. Johnson,et al.  Predicting Alzheimer’s disease progression using multi-modal deep learning approach , 2019, Scientific Reports.

[27]  Andrew Zisserman,et al.  Video Action Transformer Network , 2018, 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).

[28]  J. Molinuevo,et al.  Alzheimer’s disease prevention: from risk factors to early intervention , 2017, Alzheimer's Research & Therapy.

[29]  Martin Weygandt,et al.  Layer-Wise Relevance Propagation for Explaining Deep Neural Network Decisions in MRI-Based Alzheimer's Disease Classification , 2019, Front. Aging Neurosci..

[30]  J. Brioni,et al.  and Alzheimer's disease , 2010 .

[31]  B. Tejada-Vera,et al.  Dementia Mortality in the United States, 2000-2017. , 2019, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[32]  David Wood,et al.  NEURO-DRAM: a 3D recurrent visual attention model for interpretable neuroimaging classification , 2019, ArXiv.

[33]  Dong-Hwan Har,et al.  A Proposal of New Reference System for the Standard Axial, Sagittal, Coronal Planes of Brain Based on the Serially-Sectioned Images , 2009, Journal of Korean medical science.

[34]  Ronald J. Killiany,et al.  Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline , 2018, Diagnostics.

[35]  L. Tan,et al.  Biomarkers for preclinical Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[36]  A. Marcos,et al.  [Experimental models in Alzheimer's disease]. , 2009, Neurologia.

[37]  Ben Glocker,et al.  Attention Gated Networks: Learning to Leverage Salient Regions in Medical Images , 2018, Medical Image Anal..

[38]  Frank Hutter,et al.  Decoupled Weight Decay Regularization , 2017, ICLR.

[39]  Konstantin Nikolaou,et al.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives , 2016, Advances in Therapy.

[40]  L. Gibbons,et al.  Quality of life in Alzheimer's disease: Patient and caregiver reports. , 1999 .

[41]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[42]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[43]  Clifford R Jack,et al.  Testing the Right Target and Right Drug at the Right Stage , 2011, Science Translational Medicine.